Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 3/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | APP | P05067 | 2/20 | 0.30 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CASP1 | P29466 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.30 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9550981 | 0.96 | — | — | |
| SCHEMBL363155 | 0.84 | ALDH1A1 (0.36) | ALDH1A1TSHRTHRB | |
| SCHEMBL4216111 | 0.81 | ALDH1A1 (0.38) | ALDH1A1TSHRTHRB | |
| SCHEMBL6434546 | 0.79 | TSHR (0.47) | ALDH1A1MEN1KMT2ATSHRMAPK1 | |
| SCHEMBL277199 | 0.77 | — | — | |
| Tetraethylene Glycol SCHEMBL15376842 | 0.76 | MEN1 (0.50) | ALDH1A1MEN1KMT2ATSHRMAPK1 | |
| Pentaethylene Glycol SCHEMBL16108320 | 0.76 | ALDH1A1 (0.50) | ALDH1A1MEN1KMT2ATSHRMAPK1 | |
| Triethylene Glycol SCHEMBL15375859 | 0.76 | MEN1 (0.50) | ALDH1A1MEN1KMT2ATSHRMAPK1 | |
| Triethylene Glycol SCHEMBL1129902 | 0.76 | ALDH1A1 (0.50) | ALDH1A1MEN1KMT2ATSHRMAPK1 | |
| SCHEMBL4956991 | 0.74 | TSHR (0.38) | ALDH1A1MEN1KMT2ATSHRMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9044452-B2 | Use of resiniferatoxin (RTX) for producing an agent for treating joint pains and method for applying said agent | MESTEX AG (CH) | 2015-06-02 | — | — | US | claimed |
| EP-1838301-B1 | USE OF RESINIFERATOXIN (RTX) FOR THE PREPARATION OF AN AGENT FOR THE TREATMENT OF PAIN | MESTEX AG (CH) | 2015-01-28 | — | — | EP | claimed |
| EP-1830835-B1 | USE OF A VANILLOID RECEPTOR AGONIST TOGETHER WITH A GLYCOSAMINOGLYCAN OR PROTEOGLYCAN FOR PRODUCING AN AGENT FOR TREATING ARTICULAR PAINS AND METHOD FOR APPLYING SAID AGENT | MESTEX AG (CH) | 2012-03-14 | — | — | EP | claimed |
| US-20100196281-A1 | USE OF RESINIFERATOXIN (RTX) FOR PRODUCING AN AGENT FOR TREATING JOINT PAINS AND METHOD FOR APPLYING SAID AGENT | MESTEX AG (CH) | 2010-08-05 | — | — | US | claimed |
| US-20080153780-A1 | Use Of A Vanilloid Receptor Agonist Together With A Glycosaminoglycan Or Proteoglycan For Producing An Agent For Treating Articular Pains And Method For Applying Said Agent | MESTEX AG (CH) | 2008-06-26 | — | — | US | claimed |
| US-20080139641-A1 | Use Of Resiniferatoxin (Rtx) For Producing An Agent For Treating Joint Pains And Method For Applying Said Agent | MESTEX AG (CH) | 2008-06-12 | — | — | US | claimed |
| EP-3976081-A1 | HLA TUMOR ANTIGEN PEPTIDES OF CLASS I AND II FOR TREATING MAMMARY/BREAST CARCINOMAS | PMCR GMBH (DE) | 2022-04-06 | — | — | EP | disclosed |
| EP-3946317-A1 | COMPOSITION COMPRISING CAPSAICIN OR A CAPSACINOID FOR POSTOPERATIVE PAIN CONTROL | Mestex AG (CH) | 2022-02-09 | — | — | EP | disclosed |
| US-20220008384-A1 | COMPOSITION COMPRISING CAPSAICIN OR A CAPSACINOID FOR POSTOPERATIVE PAIN CONTROL | MESTEX AG (CH) | 2022-01-13 | — | — | US | disclosed |
| WO-2020245126-A1 | HLA TUMOR ANTIGEN PEPTIDES OF CLASS I AND II FOR TREATING MAMMARY/BREAST CARCINOMAS | PMCR GmbH (DE) | 2020-12-10 | — | — | WO | disclosed |
| WO-2020191506-A1 | COMPOSITION COMPRISING CAPSAICIN OR A CAPSACINOID FOR POSTOPERATIVE PAIN CONTROL | MESTEX AG (CH) | 2020-10-01 | — | — | WO | disclosed |
| US-9044452-B2 | Use of resiniferatoxin (RTX) for producing an agent for treating joint pains and method for applying said agent | MESTEX AG (CH) | 2015-06-02 | — | — | US | disclosed |
| US-8703741-B2 | Method of treating articular pain using a vanilloid receptor agonist together with a glycosaminoglycan or proteoglycan | MESTEX AG (CH) | 2014-04-22 | — | — | US | disclosed |
| US-20100196281-A1 | USE OF RESINIFERATOXIN (RTX) FOR PRODUCING AN AGENT FOR TREATING JOINT PAINS AND METHOD FOR APPLYING SAID AGENT | MESTEX AG (CH) | 2010-08-05 | — | — | US | disclosed |
| US-20100047181-A1 | MIXTURE OF A VANILLOID RECEPTOR AGONIST AND A SUBSTANCE INHIBITING NERVE REGENERATION, USE THEREOF FOR PRODUCING A PAINKILLER, AND METHOD FOR APPLYING SAID PAINKILLER | MESTEX AG (CH) | 2010-02-25 | — | — | US | disclosed |
| US-20080153780-A1 | Use Of A Vanilloid Receptor Agonist Together With A Glycosaminoglycan Or Proteoglycan For Producing An Agent For Treating Articular Pains And Method For Applying Said Agent | MESTEX AG (CH) | 2008-06-26 | — | — | US | disclosed |
| US-20080139641-A1 | Use Of Resiniferatoxin (Rtx) For Producing An Agent For Treating Joint Pains And Method For Applying Said Agent | MESTEX AG (CH) | 2008-06-12 | — | — | US | disclosed |